Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 2,075† | 1,147† | 1,080† | — | 1,508† |
| Net profit | 229 | 272 | 305† | 433 | 558† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| HIMANSHU AGARWAL | Executive Director | June 30, 2026 |
| UMANG VOHRA | Executive Director | June 30, 2026 |
| JAI SHANKAR KRISHNAN | Independent Director | June 30, 2026 |
| KUMARAPURAM GOPALAKRISHNAN ANANTHAKRISHNAN | Independent Director | June 30, 2026 |
| MATANGI GOWRISHANKAR | Independent Director | June 30, 2026 |
| PRAVIN UDHYAVARA BHADYA RAO | Independent Director | June 30, 2026 |
| VINOD RAO | Independent Director | June 30, 2026 |
| PANKAJ PATWARI | Non-Executive Director | June 30, 2026 |
| SHWETA JALAN | Non-Executive Director | June 30, 2026 |
| VINOD PADIKKAL | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
